非生物科学组织扩大了药物开发平台,以加快与年龄有关的疾病的治疗速度。 Nona Biosciences expands its drug development platform to speed treatments for age-related diseases.

非生物科学组织扩大了其综合发现到临床平台,增强了其在药物开发方面的能力。 Nona Biosciences has expanded its integrated discovery-to-clinical platform, enhancing its capabilities in drug development. 该公司正在推进针对与年龄有关的疾病的治疗,重点是加快研究、临床前期测试和临床试验执行。 The company is advancing its pipeline of therapies targeting age-related diseases, with a focus on accelerating research, preclinical testing, and clinical trial execution. 这一战略增长的目的是简化从早期发现到病人治疗的道路,支持更快地提供创新疗法。 This strategic growth aims to streamline the path from early-stage discovery to patient treatment, supporting faster delivery of innovative therapies.